Cover Image

Effects of Successful Versus Delayed/Failed Helicobacter pylori Eradication Therapy on Subsequent Fracture Risk: a Population‐Based Cohort Study

Fuente: Wiley Open Access

Saved in:

Bibliographic Details
Main Authors:	Jing Tong Tan, Xianhua Mao, Ching‐Lung Cheung, Poh Hwa Ooi, Wai‐Kay Seto, Wai‐K. Leung, Ka‐Shing Cheung
Format:	Artículo Open Access
Published:	Wiley 2026
Subjects:	Journal of Gastroenterology and Hepatology
Online Access:	Acceder al recurso
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Relationship between Helicobacter pylori infection, osteoporosis, and fracture
by: Jing Tong Tan, et al.
Published: (2024)

Effect of metabolic dysfunction‐associated steatotic liver disease on BNT162b2 immunogenicity against the severe acute respiratory syndrome coronavirus 2 omicron variant
by: Lok Ka Lam, et al.
Published: (2024)

Big data approach in the field of gastric and colorectal cancer research
by: Ka Shing Cheung
Published: (2024)

Proton pump inhibitors associated with severe COVID‐19 among two‐dose but not three‐dose vaccine recipients
by: Ka Shing Cheung, et al.
Published: (2024)

Noninferiority of 14‐THA for Helicobacter pylori Eradication: Reconsidering the Evidence
by: Wenjun Jiang
Published: (2026)

Helicobacter pylori Screening and Eradication in Junior High School Students in Yokosuka, Japan: Prevalence, Eradication Rates, and Challenges
by: Yoshika Saito, et al.
Published: (2025)

“Comment on: Efficacy and Safety of Semisynthetic Tetracycline Containing Quadruple Therapy for Helicobacter pylori Eradication”
by: Amina Riaz, et al.
Published: (2026)

Regression of liver fibrosis after HBsAg loss: A prospective matched case–control evaluation using transient elastography and serum enhanced liver fibrosis test
by: Lung‐Yi Mak, et al.
Published: (2024)

Gastrointestinal: Biliary Obstruction From Hepatic Artery Aneurysms: Implications for Treatment Selection
by: Derek Ngan‐Wa Wong, et al.
Published: (2024)

Randomized Comparison of Vonoprazan–Amoxicillin Dual Therapy Versus Bismuth Quadruple Therapies for Helicobacter pylori Eradication: A Multicenter Trial Evaluating National Centralized Drug Procurement Antibiotics
by: Youyu Cheng, et al.
Published: (2025)

Comment on “ Helicobacter pylori Screening and Eradication in Junior High School Students in Yokosuka, Japan: Prevalence, Eradication Rates, and Challenges” (J Gastroenterol Hepatol 2025; 40:2499–2506)
by: Hiroshi Nishida
Published: (2026)

Helicobacter pylori Infection and Cholelithiasis
by: Evangelos Kazakos, et al.
Published: (2024)

Revolution of Helicobacter pylori treatment
by: Yoshio Yamaoka
Published: (2024)

Fourteen‐and Ten‐Day Tegoprazan–Amoxicillin Dual Therapy vs. Bismuth Quadruple Therapy for Helicobacter pylori Eradication—A Noninferiority, Multicenter, Randomized Controlled Trial
by: Yan Fan, et al.
Published: (2025)

Protective or Perplexing? Rethinking the Helicobacter pylori –GERD Relationship
by: Qin Xiang Ng, et al.
Published: (2025)

Asia‐Pacific Survey on the Management of Helicobacter pylori Infection
by: Koji Otani, et al.
Published: (2024)

A Potential Impact of Helicobacter pylori Infection on Gastroesophageal Reflux Disease
by: Jannis Kountouras, et al.
Published: (2026)

Management of Helicobacter pylori Infection: Do We Completely See Eye to Eye?
by: Vaneet Jearth
Published: (2025)

Letter to the Editor Regarding “Asia‐Pacific Survey on the Management of Helicobacter pylori Infection”
by: Parena Maheshwari
Published: (2025)

Genomic analysis of Helicobacter pylori in Australia: Antimicrobial resistance, phylogenetic patterns, and virulence factors
by: Jonathon P Schubert, et al.
Published: (2024)

Helicobacter pylori and metabolic syndrome‐related adipokines in nonalcoholic fatty liver disease pathophysiology
by: J Kountouras, et al.
Published: (2024)

Evaluating vonoprazan bismuth‐containing triple therapy versus quadruple therapy for Helicobacter pylori
by: W‐Z Tang, et al.
Published: (2024)

Antibiotic Resistance in Helicobacter pylori in the Asia‐Pacific Region: A Call for Coordinated Regional Strategies
by: Koji Otani, et al.
Published: (2025)

Cost‐effective endoscopic screening for gastric cancer in a cohort with low Helicobacter pylori prevalence
by: Fumiaki Ishibashi, et al.
Published: (2024)

Efficacy and safety of tegoprazan‐ and rabeprazole‐based concomitant therapies for Helicobacter pylori infection: Real‐world evidence
by: Byung Wook Jung, et al.
Published: (2024)

Helicobacter pylori and Porphyromonas gingivalis Infections as Potential Risk Predictors for Gastric Cancer and Two Types of Esophageal Cancer
by: Jannis Kountouras, et al.
Published: (2026)

Mechanism, Association, and Actionable Evidence: Comment on Engin et al. on Helicobacter pylori and Extra‐Gastric Cancer Risk
by: Shaher Yar, et al.
Published: (2026)

Response to the Letter by Dr. Parena Maheshwari Regarding Our Manuscript, “Asia‐Pacific Survey on the Management of Helicobacter pylori Infection”
by: Koji Otani, et al.
Published: (2025)

Ten vs. 14 Days of Vonoprazan‐Based Therapy for Helicobacter pylori : Systematic Review and Meta‐Analysis of Randomized Trials
by: Tareq Alsaleh, et al.
Published: (2026)

Prevalence and Incidence of Gastric Cancer Among Helicobacter pylori –Naïve Individuals in Japan: A Systematic Review and Meta‐Analysis
by: Chikamasa Ichita, et al.
Published: (2025)

Helicobacter pylori and Metabolic Syndrome‐Related Mast Cells May Be Potential Risk Factors for the Increased Prevalence of Barrett's Esophagus
by: Jannis Kountouras, et al.
Published: (2025)

Comparative efficacy of Helicobacter pylori eradication therapy between tegoprazan‐based concomitant and bismuth quadruple therapies: A real‐world evidence
by: Yoon Suk Jung, et al.
Published: (2024)

Gastrointestinal: Successful Management of Refractory Achalasia Complicated by Delayed Diagnosis and Prolonged Sepsis
by: Dauda Bawa, et al.
Published: (2024)

A Multisite Fusion‐Based Deep Convolutional Neural Network for Classification of Helicobacter pylori Infection Status Using Endoscopic Images: A Multicenter Study
by: Duwei Dai, et al.
Published: (2025)

Is Telemedicine Enough to Eradicate Hepatitis C Virus by 2030?
by: Amina Hassan
Published: (2025)

Comparison of vonoprazan bismuth‐containing triple therapy with quadruple therapy in Helicobacter pylori‐infected treatment‐naive patients: a prospective multicenter randomized controlled trial
by: Jing Wen Liang, et al.
Published: (2024)

Chemoradiotherapy Versus Radiotherapy in Patients With Stage T1N0M0 Esophageal Cancer: A Retrospective Cohort Study
by: Run‐Zhi Wang, et al.
Published: (2025)

Comparison of Risk‐Scoring Models to Predict Gastrointestinal Bleeding in Patients With Direct Oral Anticoagulants
by: Ilsoo Kim, et al.
Published: (2024)

Ten missteps in the management of inflammatory bowel disease in Asia: An expert report by the Asian Pacific Association of Gastroenterology Working Group on Inflammatory Bowel Disease
by: Vineet Ahuja, et al.
Published: (2024)

APAGE Position Statements on Green and Sustainability in Gastroenterology, Hepatology, and Gastrointestinal Endoscopy
by: Tiing Leong Ang, et al.
Published: (2025)